Showing results (2471-2480 of 5,018) with videos related to

Sort By:
Pageof 502
International Journal of Molecular Sciences|July 4, 2018
The Involvement of PPARs in the Peculiar Energetic Metabolism of Tumor CellsAndrea Antonosante, Michele d'Angelo, Vanessa Castelli, et al.
Journal of Photochemistry and Photobiology. B, Biology|December 12, 2018
Nanostructured TiO2-induced photocatalytic stress enhances the antioxidant capacity and phenolic content in the leaves of Vitis vinifera on a genotype-dependent mannerLászló Kőrösi, Sakina Bouderias, Kristóf Csepregi, et al.
Chronobiology International|February 26, 2020
Effect of chronotype on motor skills specific to soccer in adolescent playersE Roveda, A Mulè, L Galasso, et al.
Medicina (Kaunas, Lithuania)|March 29, 2023
Pre-Test Probability Assessment and d-Dimer Based Evaluation in Patients with Previous Acute Aortic SyndromeFulvio Morello, Marco Santoro, Francesca Giachino, et al.
Gait & Posture|July 5, 2020
The relationship between tibiofemoral geometry and musculoskeletal function during normal activitySaulo Martelli, Nicola Sancisi, Michele Conconi, et al.
Thrombosis and Haemostasis|January 10, 2009
Peculiar whole blood rotation thromboelastometry (Rotem) profile in 40 sideropenic anaemia patientsLuca Spiezia, Claudia Radu, Paolo Marchioro, et al.
Veterinaria Italiana|March 20, 2024
SPREAD: Spatiotemporal Pathogen Relationships and Epidemiological Analysis DashboardAndrea De Ruvo, Alessandro De Luca, Andrea Bucciacchio, et al.
Scientific Reports|October 28, 2020
NSAIDs-dependent adaption of the mitochondria-proteasome system in immortalized human cardiomyocytesLaura Brandolini, Andrea Antonosante, Cristina Giorgio, et al.
Radiology|August 28, 2014
Respiratory motion artifact affecting hepatic arterial phase MR imaging with gadoxetate disodium is more common in patients with a prior episode of arterial phase motion associated with gadoxetate disodiumMustafa R Bashir, Patricia Castelli, Matthew S Davenport, et al.
Infection|June 18, 2016
Colitis during new direct-acting antiviral agents (DAAs) therapy with sofosbuvir, simeprevir and ribavirin for genotype 1b hepatitis CIlaria Izzo, Paola Zanotti, Claudia Chirico, et al.
Pageof 502